UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2012-06, Vol.35 (12), p.1379-1385

2012

Volltextzugriff (PDF)

Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor‐α inhibitors

Clinical and experimental dermatology, 2022-02, Vol.47 (2), p.453-455

2022

Volltextzugriff (PDF)

A randomized trial to compare the efficacy and tolerability of sodium picosulfate-magnesium citrate solution vs. 4 L polyethylene glycol solution as a bowel preparation for colonoscopy

International journal of colorectal disease, 2015-10, Vol.30 (10), p.1407-1416

2015

Volltextzugriff (PDF)

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine‐induced pancreatitis

Alimentary pharmacology & therapeutics, 2008-09, Vol.28 (5), p.623-628

2008

Volltextzugriff (PDF)

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

Inflammatory bowel diseases, 2012-05, Vol.18 (5), p.812-817

2012

Volltextzugriff (PDF)

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn’s disease

Biomedicine & pharmacotherapy, 2023-03, Vol.159, p.114225-114225, Article 114225

2023

Volltextzugriff (PDF)

Experience of patients with immune-mediated inflammatory diseases seen in a multidisciplinary integrated care unit

Journal of healthcare quality research, 2024-09, Vol.39 (5), p.283

2024

Volltextzugriff (PDF)

Matrix metalloproteinase 9 is involved in Crohn’s disease-associated platelet hyperactivation through the release of soluble CD40 ligand

Gut, 2009-07, Vol.58 (7), p.920-928

2009

Volltextzugriff (PDF)

Corticosterone as a marker of susceptibility to oxidative/nitrosative cerebral damage after stress exposure in rats

Psychoneuroendocrinology, 2007-07, Vol.32 (6), p.703-711

2007

Volltextzugriff (PDF)

P621 Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1195-i1196

2024

Volltextzugriff (PDF)

Etiopatogenia: nexos en común entre la hidradenitis supurativa y la enfermedad de Crohn

Actas dermo-sifiliográficas, 2016-09, Vol.107, p.13-20

2016

Volltextzugriff (PDF)

N-(3-(Aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats

Life sciences (1973), 2001-06, Vol.69 (4), p.479-491

2001

Volltextzugriff (PDF)

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

The New England journal of medicine, 2010-04, Vol.362 (15), p.1383-1395

2010

Volltextzugriff (PDF)

Incidence, Management, and Course of Cancer in Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2015-04, Vol.9 (4), p.326-333

2015

Volltextzugriff (PDF)

AB0706 ASSOCIATED RISK FACTORS AND OUTCOMES IN HOSPITALISED COVID-19 PATIENTS WITH BIOLOGICS AND JAK-INHIBITORS: A REPORT FROM A CENTER SPECIALISED IN IMMUNE-MEDIATED DISEASES

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1385-1385

2021

Volltextzugriff (PDF)

Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth

Breast cancer research and treatment, 2003-05, Vol.79 (2), p.241-252

2003

Volltextzugriff (PDF)

P676 Listeria monocytogenes infection in inflammatory bowel disease patients: case series

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S352-S352

2014

Volltextzugriff (PDF)

IMPLICATION OF TNF-α CONVERTASE (TACE/ADAM17) IN INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION AND INFLAMMATION IN AN EXPERIMENTAL MODEL OF COLITIS

Cytokine (Philadelphia, Pa.), 2001-12, Vol.16 (6), p.220-226

2001

Volltextzugriff (PDF)

Activity of Inducible and Neuronal Nitric Oxide Synthases in Colonic Mucosa Predicts Progression of Ulcerative Colitis

The American journal of gastroenterology, 2004-09, Vol.99 (9), p.1756-1764

2004

Volltextzugriff (PDF)

PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN

Value in health, 2019-11, Vol.22, p.S619-S619

2019

Volltextzugriff (PDF)

PGI17 COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN

Value in health, 2019-11, Vol.22, p.S619-S619

2019

Volltextzugriff (PDF)

CO0003 TREATMENT WITH BIOLOGICAL THERAPIES AND RISK OF BEING ADMITTED TO THE HOSPITAL FOR COVID19 INFECTION

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.214-215

2020

Volltextzugriff (PDF)

Refeeding syndrome in a patient with Crohn's disease

Journal of clinical gastroenterology, 2008-04, Vol.42 (4), p.430-431

2008

Volltextzugriff (PDF)

P086 Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon immune dysregulation and intestinal permeability in a stress-induced colonic inflammation

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S186-S187

2021

Volltextzugriff (PDF)

P654 Controversies in the management of anti-TNF therapy in Crohn’s disease patients. A Delphi consensus

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i782-i783

2023

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease

Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor‐α inhibitors

A randomized trial to compare the efficacy and tolerability of sodium picosulfate-magnesium citrate solution vs. 4 L polyethylene glycol solution as a bowel preparation for colonoscopy

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine‐induced pancreatitis

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn’s disease

Experience of patients with immune-mediated inflammatory diseases seen in a multidisciplinary integrated care unit

Matrix metalloproteinase 9 is involved in Crohn’s disease-associated platelet hyperactivation through the release of soluble CD40 ligand

Corticosterone as a marker of susceptibility to oxidative/nitrosative cerebral damage after stress exposure in rats

P621 Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series

Etiopatogenia: nexos en común entre la hidradenitis supurativa y la enfermedad de Crohn

N-(3-(Aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Incidence, Management, and Course of Cancer in Patients with Inflammatory Bowel Disease

AB0706 ASSOCIATED RISK FACTORS AND OUTCOMES IN HOSPITALISED COVID-19 PATIENTS WITH BIOLOGICS AND JAK-INHIBITORS: A REPORT FROM A CENTER SPECIALISED IN IMMUNE-MEDIATED DISEASES

Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth

P676 Listeria monocytogenes infection in inflammatory bowel disease patients: case series

IMPLICATION OF TNF-α CONVERTASE (TACE/ADAM17) IN INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION AND INFLAMMATION IN AN EXPERIMENTAL MODEL OF COLITIS

Activity of Inducible and Neuronal Nitric Oxide Synthases in Colonic Mucosa Predicts Progression of Ulcerative Colitis

PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN

PGI17 COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN

CO0003 TREATMENT WITH BIOLOGICAL THERAPIES AND RISK OF BEING ADMITTED TO THE HOSPITAL FOR COVID19 INFECTION

Refeeding syndrome in a patient with Crohn's disease

P086 Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon immune dysregulation and intestinal permeability in a stress-induced colonic inflammation

P654 Controversies in the management of anti-TNF therapy in Crohn’s disease patients. A Delphi consensus

Suchergebnisse filtern